Anders Gersel Pedersen

Anders Gersel Pedersen was born in 1951 and received his doctoral degree in medicine and medical sciences from Copenhagen University and an undergraduate degree from Copenhagen Business School.

He then worked for Eli Lilly for 11 years, 10 of which as a director overseeing worldwide clinical research in oncology. In 2000, he joined the Lundbeck group (a pharmaceutical company that is focused exclusively on brain diseases) as Vice-President of International Clinical Research.

He was then appointed Executive Vice-President of Drug Development and, in 2011, was appointed head of all Research and Development activities at Lundbeck.

Anders Gersel Pedersen is also Vice-Chair of Bavarian Nordic A/S and a member of a number of scientific societies, including: the Fonden Lundbeck International Neuroscience Foundation (Chair), the Danish Society for Medical Oncology, the Danish Society for Internal Medicine, the International Association for the Study of Lung Cancer, the European Society for Medical Oncology and the American Society of Clinical Oncology.